UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012988
Receipt No. R000015032
Official scientific title of the study Pathophysiological analysis of Parkinson disease using DAT scan and MRI
Date of disclosure of the study information 2014/01/28
Last modified on 2016/08/02 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Pathophysiological analysis of Parkinson disease using DAT scan and MRI
Title of the study (Brief title) Neuroimaging analysis of Parkinson disease
Region
Japan

Condition
Condition Parkinson disease
Classification by specialty
Neurology Radiology Neurosurgery
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To know the role of dopamine in vivo
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To examine lesions of decrease of dopamine
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria healthy control
Patients with Parkinson disease
Key exclusion criteria 1. communication disorder
2. serious condition of vital sign
3. no consent
4. cardiac pacemaker
5. implanted metallic or electrical devices
6. taking medicine which affects the uptake of [123I]-Ioflupane
Target sample size 20

Research contact person
Name of lead principal investigator Ryosuke Takahashi
Organization Kyoto University Graduated School of Medicine
Division name Department of Neurology
Address Kawara-machi 54, Shogo-in, Sakyo-ku, Kyoto, Japan
TEL 075-751-3771
Email sawa@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Nobukatsu Sawamoto
Organization Kyoto University Graduated School of Medicine
Division name Department of Neurology
Address Kawara-machi 54, Shogo-in, Sakyo-ku, Kyoto, Japan
TEL 075-751-3771
Homepage URL
Email sawa@kuhp.kyoto-u.ac.jp

Sponsor
Institute Department of Neurology, Kyoto University Graduated School of Medicine
Institute
Department

Funding Source
Organization Neurotransmission and research of brain function
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 01 Month 28 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 01 Month 22 Day
Anticipated trial start date
2014 Year 01 Month 22 Day
Last follow-up date
2016 Year 02 Month 01 Day
Date of closure to data entry
2016 Year 02 Month 01 Day
Date trial data considered complete
2016 Year 02 Month 01 Day
Date analysis concluded
2016 Year 02 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Prospective study

Management information
Registered date
2014 Year 01 Month 28 Day
Last modified on
2016 Year 08 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015032